Be a Part of the Fight to End Alzheimer’s
Be a Part of the Fight to End Alzheimer’s
The millions of people impacted by Alzheimer's disease need your help. Your generosity can help us provide care and support to those facing the challenges of Alzheimer's and advance global research. Please make a gift today.
Donate NowTo keep the state's residents apprised of the latest in Alzheimer's research, treatments and risk reduction, the Michigan Chapter is inviting the public to events coming up this winter and spring. These events are for anyone who has an interest in the recent information on Alzheimer's of whose lives have been touched by it. There are more than 7 million Americans living Alzheimer's. In Michigan, more than 202,800 people age 65 and older have Alzheimer's.
The FREE events will feature prominant Alzheimer's researchers from the Michigan Alzheimer's Disease Research Center. RSVP is requested. Please join us at one near you!
Wednesday, April 23, 11 a.m.-1 p.m. (Lunch will be provided.) | Frederik Meijer Gardens & Sculpture Park | Dr. David Morgan | RSVP shrobertson@alz.org or 248.996.1044
Traverse City:
Wednesday, May 7, 11:30 a.m.-1:30 p.m. (Lunch will be provided.) | Grand Traverse Resort | Dr. Bruno Giordani | RSVP kmweber@alz.org or 231.714.6736
Alpena: Thursday, May 8, 10 a.m.-noon (Refreshments will be provided.) | Art in the Loft, Center Building | Dr. Bruno Giordani | RSVP kmweber@alz.org or 231.714.6736
About the researchers
Dr. Bruno Giordani
Dr. Bruno Giordani serves as Associate Director for Michigan’s Alzheimer’s Disease Center and Chief Psychologist in the U-M Department of Psychiatry. Associated with the Center for more than 25 years, Giordani has a longstanding history of connecting with the community to promote a better understanding of Alzheimer’s disease and related disorders. His research initiatives focus on a cross-cultural perspective on the early assessment of cognitive and behavioral changes associated with medical illness.
Dr. David Morgan
Dr. David Morgan is a professor in the Department of Translational Neuroscience at Michigan State University. Morgan has advised capital investment organizations regarding the most promising therapeutic approaches to curing Alzheimer’s disease. He served for 6 years on the Program Committee for the Alzheimer's Association International Conference (AAIC), with 3 years spent as Chairperson.